{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:12:56Z","timestamp":1793661176912,"version":"4.5.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Ataxia-telangiectasia (A-T) is a rare autosomal recessive disorder caused by pathogenic <jats:italic>ATM<\/jats:italic> gene variants, characterised by progressive cerebellar ataxia, telangiectasia, immunodeficiency, and cancer predisposition. While its immunological and oncological complications are well-documented, clinical heterogeneity, particularly in cases with elevated IgM, poses diagnostic challenges.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Following written informed consent, we retrospectively analysed four pediatric A-T patients followed in our clinic. Clinical, laboratory, and radiological data were reviewed, including immunoglobulin levels, vaccine antibody responses, lymphocyte subsets, and alpha-fetoprotein (AFP) levels. Diagnosis was established based on clinical and laboratory findings, supported by whole-exome sequencing (WES) and targeted <jats:italic>ATM<\/jats:italic> gene sequencing.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Our findings further support the association between the hyper-IgM phenotype and increased immune dysfunction in A-T. We report the first globally documented case of lupus vulgaris in an A-T patient and identify a previously unreported ATM variant in our country, expanding the disease spectrum. These findings highlight the need for further research on regional genetic variations and their clinical implications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>This study highlights the importance of early diagnosis and genetic testing, particularly in atypical presentations. The recognition of novel infectious and autoimmune associations, along with novel variants, underscores the necessity of comprehensive, multidisciplinary follow-up and regional genetic screening efforts.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03942-7","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:20:03Z","timestamp":1759490403000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expanding the clinical spectrum of pediatric ataxia-telangiectasia: a case series of novel genetic variants, lupus vulgaris, and hyper-IgM phenotypes"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2317-3281","authenticated-orcid":false,"given":"Damla Baysal","family":"Bak\u0131r","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge","family":"Atay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halime","family":"Ya\u011fmur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gizem","family":"Kabaday\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Kocabey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Asilsoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nevin","family":"Uzuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"6199","key":"3942_CR1","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/336577a0","volume":"336","author":"RA Gatti","year":"1988","unstructured":"Gatti RA, Boder E, Vinters HV, Sparkes RS, Chen J, Albertini RJ. Localization of an ataxia-telangiectasia gene to chromosome 11q22\u201323. Nature. 1988;336(6199):577\u201380.","journal-title":"Nature"},{"key":"3942_CR2","doi-asserted-by":"publisher","first-page":"1228810","DOI":"10.3389\/fneur.2023.1228810","volume":"14","author":"L Shao","year":"2023","unstructured":"Shao L, Wang H, Xu J, Qi M, Yu Z, Zhang J. Ataxiatelangiectasia in china: a case report of a novel ATM variant and literature review. Front Neurol. 2023;14:1228810.","journal-title":"Front Neurol"},{"issue":"5","key":"3942_CR3","first-page":"573","volume":"39","author":"M Swift","year":"1986","unstructured":"Swift M, Morrell D, Cromartie E, Chamberlin AR, Skolnick MH, Bishop DT. The incidence and gene frequency of ataxia-telangiectasia in the united States. Am J Hum Genet. 1986;39(5):573\u201383.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"3942_CR4","doi-asserted-by":"publisher","first-page":"38","DOI":"10.21911\/aai.523","volume":"18","author":"Z\u015e Haskolo\u011flu","year":"2020","unstructured":"Haskolo\u011flu Z\u015e, Aytekin C, Bal SK, \u0130slamo\u011flu C, Bask\u0131n K, Yavuz Z, et al. Does the hyper IgM phenotype affect prognosis in ataxia telangiectasia? Asthma Allergy Immunol. 2020;18(1):38\u201346. https:\/\/doi.org\/10.21911\/aai.523.","journal-title":"Asthma Allergy Immunol"},{"issue":"5","key":"3942_CR5","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/jmedgenet-2018-105635","volume":"56","author":"NJH Van Os","year":"2019","unstructured":"Van Os NJH, Chessa L, Weemaes CMR, van Deuren M, Fi\u00e9vet A, van Gaalen J, et al. Genotypephenotype correlations in ataxia telangiectasia patients with ATM c.3576G\u2009>\u2009A and c.8147T\u2009>\u2009C mutations. J Med Genet. 2019;56(5):308\u201316.","journal-title":"J Med Genet"},{"issue":"2","key":"3942_CR6","first-page":"320","volume":"59","author":"CM McConville","year":"1996","unstructured":"McConville CM, Concannon P, Gatti RA, Anderson C, Martin K, Tessa A, et al. Mutations associated with variant phenotypes in ataxia-telangiectasia. Am J Hum Genet. 1996;59(2):320\u201330.","journal-title":"Am J Hum Genet"},{"issue":"9","key":"3942_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1212\/WNL.0b013e3182494d51","volume":"78","author":"R Saunders-Pullman","year":"2012","unstructured":"Saunders-Pullman R, Raymond D, Stoessl AJ, Hobson D, Nakamura T, Pullman S, et al. Variant ataxiatelangiectasia presenting as primaryappearing dystonia in Canadian mennonites. Neurology. 2012;78(9):649\u201357.","journal-title":"Neurology"},{"issue":"2","key":"3942_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1086\/301706","volume":"62","author":"T Stankovic","year":"1998","unstructured":"Stankovic T, Kidd AM, Sutcliffe A, McGuire GM, Robinson P, Weber P, et al. ATM mutations and phenotypes in ataxia-telangiectasia families in the British isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer. Am J Hum Genet. 1998;62(2):334\u201345.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"3942_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1365-2249.2008.03684.x","volume":"153","author":"ER Staples","year":"2008","unstructured":"Staples ER, McDermott EM, Reiman A, Byrd PJ, Ritchie S, Taylor AM, et al. Immunodeficiency in ataxiatelangiectasia is correlated strongly with the presence of two null mutations in the ataxiatelangiectasia mutated gene. Clin Exp Immunol. 2008;153(2):214\u201320.","journal-title":"Clin Exp Immunol"},{"key":"3942_CR10","unstructured":"European Society for Immunodeficiencies (ESID). Ataxia Telangiectasia Diagnostic Guidelines. Available from: https:\/\/esid.org\/Education\/Diagnostic -Criteria-PID (accessed on 6 December 2021)."},{"issue":"4","key":"3942_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jpeds.2003.12.046","volume":"144","author":"A Nowak-Wegrzyn","year":"2004","unstructured":"Nowak-Wegrzyn A, Crawford TO, Winkelstein JA, Carson KA, Lederman HM. Immunodeficiency and infections in ataxiatelangiectasia. J Pediatr. 2004;144(4):505\u201311.","journal-title":"J Pediatr"},{"issue":"1","key":"3942_CR12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/15321819.2014.891525","volume":"36","author":"P Mohammadinejad","year":"2015","unstructured":"Mohammadinejad P, Abolhassani H, Aghamohammadi A, Pourhamidi S, Sadeghi B, Nasiri Kalmarzi R, et al. Class switch recombination process in ataxia-telangiectasia patients with elevated serum levels of IgM. J Immunoass Immunochem. 2015;36(1):16\u201326.","journal-title":"J Immunoass Immunochem"},{"issue":"4","key":"3942_CR13","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1203\/01.PDR.0000139318.65842.4A","volume":"56","author":"A Etzioni","year":"2004","unstructured":"Etzioni A, Ochs HD. The hyper IgM syndrome\u2014an evolving story. Pediatr Res. 2004;56(4):519\u201325.","journal-title":"Pediatr Res"},{"key":"3942_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00262-008-0548-8","volume":"58","author":"GJ Mizejewski","year":"2009","unstructured":"Mizejewski GJ. Alpha-fetoprotein (AFP)-derived peptides as epitopes for hepatoma immunotherapy: a commentary. Cancer Immunol Immunother. 2009;58:159\u201370.","journal-title":"Cancer Immunol Immunother"},{"key":"3942_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s10875-012-9846-1","volume":"33","author":"J Mallott","year":"2013","unstructured":"Mallott J, Kwan A, Church JA, Cowan MJ, Puck JM. Newborn screening for SCID identifies patients with ataxia telangiectasia. J Clin Immunol. 2013;33:540\u20139.","journal-title":"J Clin Immunol"},{"issue":"5","key":"3942_CR16","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201323.","journal-title":"Genet Med"},{"issue":"12","key":"3942_CR17","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1002\/humu.23063","volume":"37","author":"C Marelli","year":"2016","unstructured":"Marelli C, Cusano R, Bianciardi L, Brusco A, Di Gregorio E, Traversa M, et al. Mini-exome coupled to read-depth based copy number variation analysis in patients with inherited ataxias. Hum Mutat. 2016;37(12):1340\u201353.","journal-title":"Hum Mutat"},{"key":"3942_CR18","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10048-011-0299-0","volume":"12","author":"I Demuth","year":"2011","unstructured":"Demuth I, Dutrannoy V, Marques W, Reis A, Sperling K, Schindler D, et al. New mutations in the ATM gene and clinical data of 25 AT patients. Neurogenetics. 2011;12:273\u201382. https:\/\/doi.org\/10.1007\/s10048-011-0299-0.","journal-title":"Neurogenetics"},{"issue":"1","key":"3942_CR19","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1002\/humu.20805","volume":"30","author":"M Mitui","year":"2009","unstructured":"Mitui M, Nahas SA, Du LT, Yang Z, Lai CH, Nakamura K, et al. Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk. Hum Mutat. 2009;30(1):12\u201321.","journal-title":"Hum Mutat"},{"issue":"1","key":"3942_CR20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10048-019-00597-y","volume":"21","author":"H Mutlu-Albayrak","year":"2020","unstructured":"Mutlu-Albayrak H, K\u0131rat E, G\u00fcrb\u00fcz G. Childhood-onset autosomal recessive ataxias: a cross-sectional study from Turkey. Neurogenetics. 2020;21(1):59\u201366.","journal-title":"Neurogenetics"},{"issue":"10","key":"3942_CR21","doi-asserted-by":"publisher","first-page":"103725","DOI":"10.1016\/j.ejmg.2019.103725","volume":"62","author":"E Isik","year":"2019","unstructured":"Isik E, Onay H, Atik T, Canda E, Cogulu O, Coker M, Ozkinay F. Clinical utility of a targeted next generation sequencing panel in severe and pediatric onset Mendelian diseases. Eur J Med Genet. 2019;62(10):103725. https:\/\/doi.org\/10.1016\/j.ejmg.2019.103725.","journal-title":"Eur J Med Genet"},{"issue":"2","key":"3942_CR22","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jaci.2011.03.052","volume":"128","author":"R Micol","year":"2011","unstructured":"Micol R, Ben Slama L, Suarez F, Revuz S, Haouy S, Donadieu J, et al. Morbidity and mortality from ataxia-telangiectasia are associated with ATM genotype. J Allergy Clin Immunol. 2011;128(2):382\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"3942_CR23","doi-asserted-by":"publisher","first-page":"972952","DOI":"10.3389\/fped.2022.972952","volume":"10","author":"A Szczawi\u0144ska-Pop\u0142onyk","year":"2022","unstructured":"Szczawi\u0144ska-Pop\u0142onyk A, Breborowicz A, Piotrowski A, Miko\u0142u\u0107 B, Osmola K. Infections and immune dysregulation in ataxia-telangiectasia children with hyper-IgM and non-hyper-IgM phenotypes: A single-center experience. Front Pediatr. 2022;10:972952.","journal-title":"Front Pediatr"},{"key":"3942_CR24","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13023-016-0543-7","volume":"11","author":"C Rothblum-Oviatt","year":"2016","unstructured":"Rothblum-Oviatt C, Wright J, Lefton-Greif MA, McGrath-Morrow SA, Crawford TO, Lederman HM. Ataxia telangiectasia: a review. Orphanet J Rare Dis. 2016;11:159.","journal-title":"Orphanet J Rare Dis"},{"key":"3942_CR25","doi-asserted-by":"publisher","first-page":"102947","DOI":"10.1016\/j.jaut.2022.102947","volume":"137","author":"Q Liu","year":"2023","unstructured":"Liu Q, Yin Y, Wu J, Zhang M, Wang S, Huang J, et al. T cell aging as a risk factor for autoimmunity. J Autoimmun. 2023;137:102947.","journal-title":"J Autoimmun"},{"key":"3942_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2023.08.007","volume":"263","author":"PM Kolijn","year":"2023","unstructured":"Kolijn PM, Langerak AW. Immune dysregulation as a leading principle for lymphoma development in diverse immunological backgrounds. Immunol Lett. 2023;263:1\u20137.","journal-title":"Immunol Lett"},{"issue":"e1","key":"3942_CR27","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1136\/postgradmedj-2021-140955","volume":"98","author":"S Ganai","year":"2022","unstructured":"Ganai S, Reshi R, Ahmad R, et al. Child with ataxia and red eyes. Postgrad Med J. 2022;98(e1):e1\u20132.","journal-title":"Postgrad Med J"},{"issue":"2","key":"3942_CR28","first-page":"469","volume":"26","author":"E Matutes","year":"2012","unstructured":"Matutes E. ATM germline heterozygosity does not play a role in chronic lymphocytic leukemia initiation but influences rapid disease progression through loss of the remaining ATM allele. Leukemia. 2012;26(2):469\u201370.","journal-title":"Leukemia"},{"key":"3942_CR29","doi-asserted-by":"publisher","first-page":"791522","DOI":"10.3389\/fimmu.2022.791522","volume":"13","author":"G Blanchard-Rohner","year":"2022","unstructured":"Blanchard-Rohner G, Moix I, Barthez M, Rougemont AL, Rivier F, Izquierdo I, et al. Childhood-onset movement disorders can mask a primary immunodeficiency: 6 cases of classical ataxia-telangiectasia and variant forms. Front Immunol. 2022;13:791522.","journal-title":"Front Immunol"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03942-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03942-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03942-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T11:20:08Z","timestamp":1759490408000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03942-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3942"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03942-7","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"14 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This case series was conducted in accordance with the ethical standards of our institution and the 1964 Declaration of Helsinki and its later amendments. In line with our university\u2019s ethical guidelines for case reports, institutional ethics committee approval is not required when only anonymized patient data are analyzed retrospectively. Nevertheless, written informed consent to participate in the study was obtained from the parents\/legal guardians of all patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the parents\/legal guardians of all patients, explicitly granting permission for the use of their anonymized medical data and clinical photographs in this open access publication, which will be freely accessible online under the Creative Commons Attribution (CC BY) license.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration number"}}],"article-number":"500"}}